Development In Treating Fibromyalgia
20/09/2018 13:22
Sept 20 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA ANNOUNCES SIGNIFICANT PROGRESS ON STORZ &
BICKEL CO-DEVELOPMENT IN TREATING FIBROMYALGIA
* TETRA BIO PHARMA - EXPECTS TO COMPLETE IDENTIFICATION OF
EVERY
COMPOUND IN PPP001 VAPOR GENERATED BY MIGHTY MEDIC VAPORIZER
LATER THIS MONTH
Source text for Eikon: ID:nGNX9vMvm9
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding